Route 92 Medical Raises Over $31 Million In Oversubscribed Series F Equity Financing To Accelerate Its Commercialization Into The Rapidly Growing Stroke Treatment Market
Amount Raised
$31 Million
Round Type
Series F
San MateoManufacturingBiotechnologyHealthcareFinancial ServicesHealth CareMedicalDescription
Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention portfolio focused on acute ischemic stroke. The oversubscribed capital raise was led by existing venture capital investors: U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group.
Who to call at Route 92 Medical, and when
A new round usually means Route 92 Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Route 92 Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Route 92 Medical, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Route 92 Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Route 92 Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.